FDA Releases Draft Honey Labeling Guidance
The U.S. Food and Drug Administration (FDA) has issued draft guidance concerning the proper labeling of honey and honey products to ensure that such products “are not adulterated or misbranded.” In light of its earlier refusal to create a new standard of identity for honey, the agency developed the guidance to respond to labeling issues raised by a March 8, 2006, petition submitted by the American Beekeeping Federation and other honey-related associations.
According to FDA, the draft guidance (i) “summarizes FDA’s legal authority over honey and honey products”; (ii) “provides a commonly used definition of honey”; (iii) “offers advice on labeling issues such as the floral source of honey, blends of honey and other sweeteners, and blends of honey and other ingredients, such as flavors”; and (iv) “describes some of the measures FDA takes to guard against honey adulterated with cane sugar, corn syrup, or residues of chloramphenicol or fluoroquinolones.” The agency has requested comments on the draft guidance before June 9, 2014. See CFSAN Constituent Update, April 8, 2014; Federal Register, April 9, 2014.
Issue 520
